About Sensimed
Sensimed is a company based in Lausanne (Switzerland) founded in 2003 was acquired by SEED in December 2019.. Sensimed has raised $41.82 million across 4 funding rounds from investors including Seed, Vertex Ventures and Wellington Partners Venture Capital. Sensimed offers products and services including SENSIMED Triggerfish. Sensimed operates in a competitive market with competitors including Ivantis, Transcend Medical, Alievio, i-Optics and Implandata, among others.
- Headquarter Lausanne, Switzerland
-
Sectors
TechnologyHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sensimed S.A.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sensimed
Sensimed offers a comprehensive portfolio of products and services, including SENSIMED Triggerfish. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Smart contact lens for 24-hour eye pressure monitoring in glaucoma.
Funding Insights of Sensimed
Sensimed has successfully raised a total of $41.82M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $8.27 million completed in July 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $8.3M
-
First Round
First Round
(17 Dec 2007)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2013 | Amount | Series C - Sensimed | Valuation | Vertex Ventures |
|
| Nov, 2012 | Amount | Series C - Sensimed | Valuation | Wellington Partners Venture Capital , Agate | |
| May, 2010 | Amount | Series B - Sensimed | Valuation | Wellington Partners Venture Capital , Renaissance |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sensimed
Sensimed has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Seed, Vertex Ventures and Wellington Partners Venture Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in early-stage healthcare startups.
|
Founded Year | Domain | Location | |
|
Growth capital is provided to mature MedTech companies by Agate.
|
Founded Year | Domain | Location | |
|
A family office service is provided by Sandoz Family Foundation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sensimed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sensimed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sensimed Comparisons
Competitors of Sensimed
Sensimed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ivantis, Transcend Medical, Alievio, i-Optics and Implandata, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Implantable device to relieve intraocular pressure in open angle glaucoma
|
|
| domain | founded_year | HQ Location |
Minimally invasive glaucoma stents are developed to enhance aqueous outflow.
|
|
| domain | founded_year | HQ Location |
A noninvasive glaucoma device is developed to drain aqueous humor.
|
|
| domain | founded_year | HQ Location |
i-Optics specializes in providing advanced retina and cornea imaging systems for medical professionals.
|
|
| domain | founded_year | HQ Location |
Intraocular pressure is monitored continuously via an implantable microsensor.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sensimed
Frequently Asked Questions about Sensimed
When was Sensimed founded?
Sensimed was founded in 2003 and raised its 1st funding round 4 years after it was founded.
Where is Sensimed located?
Sensimed is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Is Sensimed a funded company?
Sensimed is a funded company, having raised a total of $41.82M across 4 funding rounds to date. The company's 1st funding round was a Series B of $8.64M, raised on Dec 17, 2007.
What does Sensimed do?
Sensimed was founded in 2003 in Lausanne, Switzerland, and operates in the medical device sector focused on ophthalmology. A non-invasive soft contact lens solution for glaucoma management is provided by the company. Continuous ocular dimensional changes are recorded automatically over a full day. The platform has received CE and FDA approvals, supporting clinical monitoring needs in eye health.
Who are the top competitors of Sensimed?
Sensimed's top competitors include Ivantis, Transcend Medical and Alievio.
What products or services does Sensimed offer?
Sensimed offers SENSIMED Triggerfish.
Who are Sensimed's investors?
Sensimed has 8 investors. Key investors include Seed, Vertex Ventures, Wellington Partners Venture Capital, Agate Medical Investments, and Renaissance.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.